SEC Tracker
Get the app

Insight Molecular Diagnostics IMDX

IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Insight Molecular Diagnostics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2835 and related industry codes: the same peer list as the financial tables.

  1. Rein Therapeutics RNTX public float $32M, Jun 30, 2025
  2. Yarrow Bioscience VYNE public float $32M, Jun 30, 2025
  3. Kezar Life Sciences KZR public float $33M, Jun 30, 2025
  4. Scorpius Holdings SCPX
  5. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025